Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 12, Décembre 2011
Page(s) 1058 - 1061
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20112712007
Publié en ligne 23 décembre 2011
  1. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 2006 ; 127 : 469–480. [CrossRef] [PubMed]
  2. Taelman VF, Dobrowolski R, Plouhinec JL, et al. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 2010 ; 143 : 1136–1148. [CrossRef] [PubMed]
  3. MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009 ; 17 : 9–26. [CrossRef] [PubMed]
  4. Platta HW, Stenmark H. Endocytosis and signaling. Curr Opin Cell Biol 2011 ; 23 : 1–11. [CrossRef] [PubMed]
  5. Van den Heuvel M, Nusse R, Johnston P, Lawrence PA, Lawrence PA. Distribution of the wingless gene product in Drosophila embryos: a protein involved in cell-cell communication. Cell 1989 ; 59 : 739–749. [CrossRef] [PubMed]
  6. Sutherland C. What are the bona fide GSK3 substrates? Int J Alzheimer Dis 2011 ; 2011 : 505–607.
  7. Fiol CJ, Wang A, Roeske RW, Roach PJ. Ordered multisite protein phosphorylation. Analysis of glycogen synthase kinase 3 action using model peptide substrates. J Biol Chem 1990 ; 265 : 6061–6065. [PubMed]
  8. Dajani R, Fraser E, Roe SM, et al. Crystal structure of glycogen synthase kinase 3β: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 2001 ; 105 : 721–732. [CrossRef] [PubMed]
  9. Mosesson Y, Mills GB, Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 2008 ; 8 : 835–850. [CrossRef] [PubMed]
  10. Rocques N, Abou Zeid N, Sii-Felice K, et al. GSK-3-mediated phosphorylation enhances Maf-transforming activity. Mol Cell 2007 ; 28 : 584–597. [CrossRef] [PubMed]